| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 5 |
| 1 | FLUOROURACIL CREAM, 0.5% | 5 |
| 2 | OXALIPLATIN | 5 |
| 3 | DUPILUMAB | 2 |
| 4 | RIBAVIRIN | 2 |
| 5 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 2 |
| 6 | ALBUTEROL SULFATE | 1 |
| 7 | AZITHROMYCIN | 1 |
| 8 | AZITHROMYCIN DIHYDRATE | 1 |
| 9 | AZITHROMYCIN MONOHYDRATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 2 | 0.0018 |
| 1 | OXALIPLATIN | 5 | 0.0001 |
| 2 | FLUOROURACIL CREAM, 0.5% | 5 | 0.0001 |
| 3 | FLUOROURACIL | 5 | 0.0001 |
| 4 | INSULIN DEGLUDEC | 1 | 0.0000 |
| 5 | RIBAVIRIN | 2 | 0.0000 |
| 6 | AZITHROMYCIN MONOHYDRATE | 1 | 0.0000 |
| 7 | METFORMIN HYDROCHLORIDE TABLETS | 1 | 0.0000 |
| 8 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 1 | 0.0000 |
| 9 | METFORMIN HYDROCHLORIDE TABLET | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 2 | 0.0001 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 5 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 6 | Acetylcholine Release Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Expectorant [EPC] | 1 | 0.0000 |
| 9 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2 | 0.0000 |